Phase 2A study of ataluren in hemophilia a and B (IND 104,321)
Ended Project Grant Awarded Last action
- Award ID
- RC1HL100159
- Recipient
-
PTC Therapeutics, Inc. UEI LH7QEHP9V7W1
- Awarding agency
-
National Institutes of Health
Department of Health and Human Services
- Obligated
- $996,430
Award facts
- Assistance listing
- 93.701 Trans-NIH Recovery Act Research Support
- Completion date
- Place of performance
- South Plainfield, NJ 07080, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $498,215 | |
| Original award | $498,215 |
Quick answers
Who received award RC1HL100159?
RC1HL100159 was awarded to PTC Therapeutics, Inc. by National Institutes of Health (Department of Health and Human Services) on September 30, 2009.
How much is award RC1HL100159 worth?
$996,430 has been obligated on RC1HL100159.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award